Literature DB >> 13749676

Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion.

A SEGALOFF, J B WEETH, E L RONGONE, P J MURISON, C Y BOWERS.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/therapy; PROGESTERONE/related compounds

Mesh：

Substances：

Year:  1960        PMID： 13749676     DOI： 10.1002/1097-0142(196009/10)13:5<1017::aid-cncr2820130523>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Treatment of intra-abdominal and abdominal wall desmoid tumors with drugs that affect the metabolism of cyclic 3',5'-adenosine monophosphate.

Authors:  W R Waddell
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

2.  Research at ochsner clinic: highlights in its history.

Authors:  Hector O Ventura
Journal:  Ochsner J       Date:  2007

Review 3.  Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Authors:  V C Njar; A M Brodie
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

4.  Hormonal treatment of disseminated cancer of the female breast.

Authors:  G S GORDAN; W P GRAHAM; L GOLDMAN; R PAPAC; G E SHELINE; J VAETH; J WITT
Journal:  Calif Med       Date:  1963-04

Review 5.  Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

Authors:  P E Lønning; M Dowsett; T J Powles
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.